This inventor holds 12 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Astellas Pharma Gmbh, Curegene K.k., United Immunity, Co., Ltd.. Active years: 2008-2026.
Location History:
- Ibaraki, JP (2008 - 2010)
- Tokyo, JP (2009 - 2018)
Company Filing History:
10 out of 424 
6 out of 6 
2 out of 2 Years Active: 2008-2026
Title: Takatoshi Soga: Innovator in Cancer Research
Introduction
Takatoshi Soga is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, particularly through his innovative work on fusion genes. With a total of 12 patents to his name, Soga's inventions have the potential to impact cancer diagnosis and treatment.
Latest Patents
One of Soga's latest patents focuses on the EML4-ALK fusion gene. The present inventors discovered that this fusion gene, found in some cancer patients, acts as an oncogene. The invention includes a polypeptide as a novel fusion protein, a polynucleotide encoding the polypeptide, and a vector comprising the polynucleotide. Additionally, it encompasses a transformed cell containing the vector, methods for detecting the fusion protein or polynucleotide, and methods for screening therapeutic agents for cancer. Furthermore, the invention provides a method for treating cancer that tests positive for the fusion gene, along with a kit, primer set, and probe useful in the detection of cancer associated with this fusion gene.
Career Highlights
Throughout his career, Takatoshi Soga has worked with notable companies such as Astellas Pharma GmbH and Curegene K.K. His work in these organizations has allowed him to advance his research and contribute to the development of innovative cancer therapies.
Collaborations
Soga has collaborated with esteemed colleagues, including Hiroyuki Mano and Sadao Kuromitsu. These partnerships have further enriched his research and expanded the impact of his inventions in the medical field.
Conclusion
Takatoshi Soga's contributions to cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer diagnosis and treatment.